13th International Conference on Pathways, Networks, and Systems Medicine

Preliminary Program

Sunday, June 23

7:00 PM

 

Conference Registration

8:00 PM

 

Welcome Reception and Dinner

Monday, June 24

7:30 AM

 

Breakfast

8:30 AM

 

Welcome and Opening Remarks

SESSION I

 

Systems Medicine

Chair: Ellen Rothenberg

8:40 AM

1

An update on the clinical development of the compstatin based drug candidate AMY-101

John Lambris

9:05 AM

2

Diverse Approaches to Novel Gene Discovery in Founder and Special Populations at the Regeneron Genetics Center

Nehal Gosalia, Claudia Gonzaga-Jauregui, Cristopher Van Hout, Alan Shuldiner, and Aris Economides

9:30 AM

3

Investigating the role of CD28 in enhancing CAR-mediated signaling in T cells using systems biology

Jennifer Rohrs, Pin Wang, and Stacey Finley

9:55 AM

4

Microbiomes over time and space

Rob Knight

10:20 AM

5

Mapping pathways for Biliary atresia, a developmental disease, with Integrative analysis of multiomics data

Rakesh Sindhi, Donghun Shin, and Shankar Subramaniam

10:45 AM

6

Noisy biological systems

Joe Nadeau

11:10 AM

 

Coffee Break and Poster Viewing

SESSION II

 

Single Cell and Technologies

Chair: Stacey Finley

11:45 AM

7

Single-cell dissection of the gene regulatory network controlling entry into the T-cell developmental pathway

Ellen Rothenberg, Wen Zhou, and Xun Wang

12:10 PM

8

single-cell measurement and control to unravel yeast gene expression heterogeneity

Megan McClean, Kieran Sweeney, and Audrey Gasch

12:35 PM

9

Mapping trajectories of drug-induced tumor evolution “one cell at-a-time”

Ramanuj Dasgupta

1:00 PM

10

ToppCell: A workbench for the analysis, modeling and prediction of transcriptional networks responsible for the development and function of cells and tissues based on single cell atlas datasets

Alexis Mitelpunkt, Jake Wang, Eric Bardes, Kang Jin, Balaji Iyer, Saif Alimohamed, Scott Tabar, and Bruce Aronow

1:25 PM

11

Founder populations for discovery and therapeutic development

Nehal  Gosalia, Bin  Ye, Cristopher Van Hout, and Alan  Shuldiner

1:50 PM

12

Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans

Thomas Hagan, Mario Cortese, Nadine Rouphael, Mohan Maddur, Jun Zou, Andrew Gewirtz, Surender Khurana, Hana Golding, Shuzhao Li, and Bali Pulendran

2:15 PM

 

Lunch and Informal Discussions

7:30 PM

 

Dinner and Informal Discussions

Tuesday, June 25

7:30 AM

 

Breakfast

SESSION III

 

Neuronal Systems

Chair: Gabriel Haddad

8:30 AM

13

Identifying gene modules that remodel multiple components of the cellular machinery during developmental state transitions in embryonic stem cells

Noel Buckley and Shankar Subramaniam

8:55 AM

14

Role of chromatin remodeling in mechanisms associated with Familial Alzheimer’s Disease

Andrew Caldwell, Qing Liu, Douglas Galasko, Shauna Yuan, Steven Wagner, and Shankar Subramaniam

9:20 AM

15

A systems biology approach to understanding ALS pathogenesis in iPSC-derived motor neurons

Leslie M Thompson and the NeuroLINCS and Answer ALS Consortia

 

9:45 AM

16

Cell state reprogramming and oncogene-induced plasticity in glioblastoma

Dinorah Friedmann-Morvinski, Inbar Angel, Ori Pilo Kerman, and Liat Rousso-Noori

10:10 AM

17

Mechanisms Impairing Neural Development in Schizophrenia (MINDS)

Francis Szele, Yichen LI, Anthony  James, Istvan Adorjan, Angela Russell, and Abeer Al-Shammari

10:35 AM

18

Histone acetylome-wide association studies: autism spectrum disorder and tuberculosis

Shyam Prabhakar

11:00 AM

 

Coffee Break and Poster Viewing

SESSION IV

 

Cancer Biology

Chair: Raimond Winslow

11:45 AM

19

Systems biology approach to early detection of biologically aggressive cancers

Victoria Seewaldt, Jerneja  Tomsic, Joseph Geradts, Long  Cai, and Lihong Wang

12:10 PM

20

Biological Markers for Colorectal Cancer

Kavitha Mukund, Natalia Syulyukina, Shankar Subramaniam, and Sonia Ramamoorthy

12:35 PM

21

Understanding and exploiting Cancer Mechanobiology

Adam Engler

1:00 PM

22

Dissecting the molecular basis of Marfanoid Progeroid Lipodystrophy Syndrome by multi-omics approach.

Giusy Della Gatta, Christopher  Schoenherr, Lawrence Miloscio, Trikaldarshi Persaud, Gannie Tzoneva, Silvia Smaldone, Erika Troy, and Aris Economides

1:25 PM

23

Co-phosphorylation networks and their application in predicting kinase-substrate associations and cancer subtyping

Mehmet Koyuturk, Marzieh Ayati, and Mark Chance

1:50 PM

24

Recombination and Repair at Stalled Mammalian Replication Forks
Ralph Scully

2:15 PM

 

Lunch and Informal Discussions

7:30 PM

 

Dinner and Informal Discussions

Wednesday, June 26

7:30 AM

 

Breakfast

SESSION V

 

Metabolism

Chair: Noel Buckley

8:30 AM

25

Using lipidomics to identify therapeutic targets.

Michael Wakelam, An Nguyen, Qifeng Zhang, and Andrea Lopez-Clavijo

8:55 AM

26

Dysregulation of the lysophospholipid/autotaxin axis defines the cardiovascular risk SNP rs10757274 on chromosome 9p21

Valerie O'Donnell

9:20 AM

27

Amino acid metabolism and lipid diversity link cancer and neuropathy

Christian Metallo

9:45 AM

28

Metabolic crosstalk between mammalian cells and Clostridium difficile bacteria

Alexander Heinz, Jasmin  Hanke, Kerstin Schmidt-Hohagen, and Karsten Hiller

10:10 AM

29

Nuclear one-carbon metabolism in embryonic development and disease.

Patrick Stover, Martha Field, and Eunice Awuah

10:35 AM

30

Advances In  Obesity Metabolic Surgery

Santiago Horgan

11:00 AM

 

Coffee Break and Poster Viewing

SESSION VI

 

Cardiac & Muscle

Chair: Joe Nadeau

11:30 AM

31

Re-introducing the Patient Context into Cardiac Drug Discovery using iPSC Disease Models

Mark Mercola

11:55 AM

32

Transcriptional Dysregulation in Muscle From Children with Cerebral Palsy

Richard Lieber

12:20 PM

33

Longitudinal Analysis of Myogenic Differentiation Mechanisms

Priya Nayak, Shyni  Varghese, and Shankar  Subramaniam

12:45 PM

34

Computational Cardiology: From the Molecule to the Patient

Natalia Trayanova

1:10 PM

35

FSTL1 Post-Transcriptional Modifications  (or mechanisms to regulate cardiac regeneration)

Pilar  Ruiz-Lozano

1:35 PM

 

Lunch and Informal Discussions

3:30 PM

 

City Tour

7:30 PM

 

Dinner and Informal Discussions

Thursday, June 27

7:30 AM

 

Breakfast

SESSION VII

 

Disease and Systems Biology

Chair: Christian Metallo

8:30 AM

36

Genomic and signaling pathway analysis of high altitude hypoxia-induced excessive erythropoiesis in subjects with Monge’s disease

Priti Azad, Arya Iranmehr, Dan Zhou, Vineet  Bafna, and Gabriel Haddad

8:55 AM

37

Predicting Patient Risk in Septic Shock

Raimond L Winslow, Joseph  Greenstein, and Ran  Liu

9:20 AM

38

Integration of genetic, transcriptomic, proteomic and metabolomic analysis to understand the basis of cardiometabolic health.

Charles Burant

9:45 AM

39

Tackling the diseases of ageing: from chemistry to stem cells and regenerative medicine

Angela Russell

10:10 AM

40

Epigenetic regulation of metabolic disease heterogeneity

Andrew Pospisilik

10:35 AM

41

Bridging the gap: connecting biochemical and mechanical activators of tissue gap repair

Allyson Sgro

11:00 AM

 

Coffee Break and Poster Viewing

SESSION VIII

 

Development and Disease

Chair: Aris Economides

11:30 AM

42

Therapeutic strategies via genome engineering: new approaches and new challenges.

Prashant Mali

11:55 AM

43

Epigenetic inheritance in mammals

Anne Ferguson-Smith

12:20 PM

44

Genome-wide Analysis of Enhancers in Development and Disease

Bing Ren

12:45 PM

45

Blood Cell Fate Decisions: insights from single-cell RNA-seq

Merav Socolovsky

1:10 PM

46

Mechanical cues coordinating cell behaviors during morphogenesis

Karen Kasza

1:35 PM

47

Interaction of membrane cholesterol with G protein-coupled receptors: a multidimensional approach

Amitabha Chattopadhyay

2:00 PM

 

Closing Remarks

2:05 PM

 

Lunch and Informal Discussions

8:00 PM

 

Farewell Dinner

Friday, June 28

7:30 AM

 

Breakfast

10:00 AM

 

Departure

POSTERS

48

Fuzzy Inferred Kalman Filter (FIKF): An efficient parameter estimation approach in biochemical pathway modeling

Abhisek  Bakshi, Abhijit Dasgupta, and Rajat De

49

In silico modeling of integrated biochemical pathways: A three-timescale system

Abhijit Dasgupta, Abhisek Bakshi, and Rajat De

50

5LOX is associated with high metabolic activity and poor overall survival in oesophageal adenocarcinoma, and this pathway represents a novel target in OAC

Zivile Useckaite, Vinod Malik, Aoife Maguire, John Reynolds, and Graham  Pidgeon

51

Constructing regulatory networks from transcriptional data to explore the pathways controlled by miR-96

Morag Lewis, Miguel Moreno-Pelayo, and Karen Steel

52

Transcription factor Irf6 is a critical mediator of the ErbB2/Her2 signalling pathway

Iman   Khan, Byong   Yoo, Michael  McPhee, Olivier  Masson, Alexi  Surette , Kelly  Dakin-Hache, Tallal  Younis, Gillian  Bethune, and Kirill Rosen

53

Macroecological dynamics of gut microbiota

Dennis Vitkup

54

The Microsetta Initiative: Creating a Map of the Global Gut Microbiome

Daniel McDonald, Justin Shaffer, Jordan Bisanz, Gregor Reid, Maria Gloria Dominguez-Bello, Emily Vogtmann, Mathilde Poyet, Mathieu Groussin, Eric Alm, and Rob Knight

55

Development of a non-invasive biosensor for diagnosis of circadian clock disorders

Silvana Papagerakis, Nikos Chronis, and Petros Papagerakis